TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 128 filers reported holding TREACE MED CONCEPTS INC in Q4 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,942 | +1128.1% | 5,856 | +2309.9% | 0.00% | – |
| Q1 2024 | $3,171 | -97.4% | 243 | -97.5% | 0.00% | -100.0% |
| Q4 2023 | $121,712 | +127.5% | 9,546 | +133.9% | 0.00% | 0.0% |
| Q3 2023 | $53,501 | +17.2% | 4,081 | +128.6% | 0.00% | 0.0% |
| Q2 2023 | $45,660 | +175515.4% | 1,785 | +72.8% | 0.00% | +100.0% |
| Q1 2023 | $26 | -72.3% | 1,033 | -74.5% | 0.00% | -75.0% |
| Q4 2022 | $94 | -99.9% | 4,053 | -24.4% | 0.00% | +100.0% |
| Q3 2022 | $118,000 | +107.0% | 5,363 | +35.2% | 0.00% | +100.0% |
| Q2 2022 | $57,000 | +111.1% | 3,966 | +181.7% | 0.00% | – |
| Q1 2022 | $27,000 | +92.9% | 1,408 | +88.7% | 0.00% | – |
| Q4 2021 | $14,000 | +55.6% | 746 | +124.0% | 0.00% | – |
| Q3 2021 | $9,000 | +200.0% | 333 | +278.4% | 0.00% | – |
| Q2 2021 | $3,000 | – | 88 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 750,000 | $4,987,500 | 2.25% |
| Soleus Capital Management, L.P. | 2,365,648 | $15,731,559 | 1.39% |
| GAGNON SECURITIES LLC | 483,581 | $3,215,814 | 0.72% |
| ARMISTICE CAPITAL, LLC | 5,360,000 | $35,644,000 | 0.45% |
| Divisadero Street Capital Management, LP | 114,400 | $760,760 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 191,427 | $1,273 | 0.09% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 212,976 | $1,416,290 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 526,918 | $3,504,005 | 0.07% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,681,718 | $24,483,425 | 0.06% |
| Lighthouse Investment Partners, LLC | 167,500 | $1,113,875 | 0.04% |